A Phase II Study to Evaluate the Efficacy and Safety of F520 Combined With F007 in Patients With RR DLBCL
Clinical trial NCT05178836 · UNKNOWN
Trial details
- NCT number
- NCT05178836
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-12-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.